Soluble polypeptides for use in treating autoimmune and...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/435 (2006.01) A61K 38/17 (2006.01) C07K 14/705 (2006.01) C12N 1/15 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) C12N 15/68 (2006.01)

Patent

CA 2747678

The present invention relates to soluble CD47 binding polypeptides, for use as a medicament, in particular for the prevention or treatment of autoimmune and inflammatory disorders, for example allergic asthma and inflammatory bowel diseases. The Invention more specifically relates to a soluble CD47 binding polypeptide for use as a medicament, comprising an extracellu-lar domain of SIRP.alpha. (CD172a) or functional derivatives which bind to human CD47.

La présente invention concerne des polypeptides de liaison à CD47 solubles pouvant être employés en tant que médicaments, en particulier dans la prévention ou le traitement de troubles auto-immuns et inflammatoires, par exemple de l'asthme allergique et des affections abdominales inflammatoires. La présente invention concerne plus spécifiquement un polypeptide de liaison à CD47 soluble pouvant être employé en tant que médicament, comprenant un domaine extracellulaire de SIRPa (CD172a) ou des dérivés fonctionnels se liant au CD47 humain.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Soluble polypeptides for use in treating autoimmune and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Soluble polypeptides for use in treating autoimmune and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble polypeptides for use in treating autoimmune and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1350286

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.